InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the detailed record of transactions filed by Mayersohn Joel David. Director active across 1 company, notably CITIUS ONCOLOGY, INC.. Aggregated, 4 disclosures have been published. History available since 28 July 2025. The latest transaction was disclosed on 19 September 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Mayersohn Joel David is a declarant and Director of CITIUS ONCOLOGY, INC. He has 4 filings in total, and across the 4 recent filings available, the modal transaction nature is Attribution, with buy and sell amounts of EUR 0 each, from 2025-08-07 to 2025-12-22.